ClinicalTrials.Veeva

Menu

The Role of Resistance Training in Non Alcoholic Fatty Liver Disease

T

Tel Aviv Sourasky Medical Center

Status

Completed

Conditions

Resistance Training
NAFLD (Non-Alcoholic Fatty Liver Disease)

Treatments

Behavioral: Resistance Training

Study type

Interventional

Funder types

Other

Identifiers

NCT01264198
TASMC-10-RO-330-CTIL

Details and patient eligibility

About

The aim of the study is to evaluate the effect of RT on clinical and metabolic parameters in patients with NAFLD.

Full description

Background: Non Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent liver disease in developed countries with a prevalence rate of 20-30 % of adults. About 10-25% of these individuals are estimated to meet the current diagnostic criteria for Non Alcoholic Steatohepatitis (NASH) and some may progress to Cirrhosis and liver failure. NAFLD is now recognized as the hepatic manifestation of the metabolic syndrome. Recent data shows that NAFLD might also predict the tendency to develop diabetes mellitus and coronary artery disease. The drug of choice for NAFLD is yet to be found. The recommended treatment of NAFLD includes weight reduction and Physical Activity (PA), but the data of the effect of Resistance Training (RT) PA on NAFLD is scant.

Aim of the study: To evaluate the effect of RT on clinical and metabolic parameters in patients with NAFLD. Study design: Randomized Clinical Trial. Patients will be randomly allocated to 2 arms (intervention and control). The intervention arm will perform RT, whereas control arm will be advised to perform home stretching. Medical examination will be performed at week 0 (baseline) and at week 13 using uniform protocols.

Enrollment

82 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ultrasound diagnosed fatty liver.

Exclusion criteria

  • Presence of HBsAg or anti-HCV antibodies (will be obtained from blood tests at the liver clinic).
  • Patients with known diabetes treated with antidiabetic medications.
  • Patients with known kidney disease, CHD, lung disease, inflammatory bowel disease.
  • Excessive alcohol consumption ≥ 30 g/day in men or 20 g/ day in women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

82 participants in 2 patient groups

Stretching Exercises
Sham Comparator group
Description:
The patients will perform twice weekly home based static stretching workout.
Treatment:
Behavioral: Resistance Training
Resistance Training
Experimental group
Description:
The patients will perform twice weekly supervised RT for 3 months
Treatment:
Behavioral: Resistance Training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems